Page last updated: 2024-08-18

cyclohexanol and Pheochromocytoma

cyclohexanol has been researched along with Pheochromocytoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
King, KS; Neary, NM; Pacak, K	1
Baumann, B; Erlandsson, N; Giehl, KM; Kaufmann, K; Rössler, OG; Thiel, G; Wirth, T	1

Other Studies

2 other study(ies) available for cyclohexanol and Pheochromocytoma

Article	Year
Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine. The New England journal of medicine, 2011, Jun-09, Volume: 364, Issue:23 Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Cyclohexanols; Female; Humans; Metanephrine; Middle Aged; Mutation; Normetanephrine; Pheochromocytoma; Selective Serotonin Reuptake Inhibitors; Succinate Dehydrogenase; Venlafaxine Hydrochloride	2011
Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940. Biochemical pharmacology, 2002, Aug-01, Volume: 64, Issue:3 Topics: Adrenergic Agents; Animals; Apoptosis; Cyclic AMP; Cyclohexanols; DNA-Binding Proteins; I-kappa B Proteins; Immunosuppressive Agents; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidopamine; PC12 Cells; Pheochromocytoma; Rats; Receptors, Cannabinoid; Receptors, Drug; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	2002

Article

Year

Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine.

The New England journal of medicine, 2011, Jun-09, Volume: 364, Issue:23

Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Cyclohexanols; Female; Humans; Metanephrine; Middle Aged; Mutation; Normetanephrine; Pheochromocytoma; Selective Serotonin Reuptake Inhibitors; Succinate Dehydrogenase; Venlafaxine Hydrochloride

2011

Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940.

Biochemical pharmacology, 2002, Aug-01, Volume: 64, Issue:3

Topics: Adrenergic Agents; Animals; Apoptosis; Cyclic AMP; Cyclohexanols; DNA-Binding Proteins; I-kappa B Proteins; Immunosuppressive Agents; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidopamine; PC12 Cells; Pheochromocytoma; Rats; Receptors, Cannabinoid; Receptors, Drug; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2002